Navigable Slide Index

1. Introduction
2. Agenda
3. Gastroparesis - definition
4. Diabetic gastropathy
5. Suggestive symptoms for gastroparesis
6. Magnitude
7. Causes for gastroparesis
8. Functional parts of the stomach
9. Pathophysiology of gastroparesis
10. Factors that slow gastric emptying
11. Range of gastric dysmotility
12. Evaluation of gastroparesis
13. Gastric scintigraphy
14. Advantages of gastric emptying scans
15. Disadvantages of gastric emptying scans
16. Wireless motility capsule (WMC)
17. WMC vs. gastric emptying
18. Gastroduodenal manometry
19. Other emptying tests
20. Current treatment of gastroparesis
21. Medications that slow gastric emptying
22. Dietary recommendations
23. Three-step dietary treatment
24. Nutritional status
25. Prokinetic therapies
26. Metoclopramide
27. Side effects of Metoclopramide
28. Metoclopramide and tardive dyskinesia
29. Domperidone
30. Domperidone and gastroparesis
31. Cisapride
32. Erythromycin
33. Summary - prokinetic agents
34. Antiemetic therapies
35. Botulinum toxin
36. Botox and gastroparesis: a systematic review
37. Surgery and gastroparesis
38. Gastric stimulation
39. Gastric stimulation: MOA
40. Gastric stimulation studies
41. Gastric stimulation: the bottom line
42. Future drugs
43. Behavioral therapy and psychopharmacology
44. Potential non-drug treatments
45. Dyspepsia
46. Dyspeptic symptoms
47. Dyspepsia subgroups
48. Rome III- functional dyspepsia (FD)
49. Rome III- post prandial distress syndrome
50. Rome III- epigastric pain syndrome
51. Why change in Rome III
52. Dyspepsia/GERD/IBS
53. Pathophysiology - motor and sensory
54. Delayed gastric emptying
55. Acid hypersensitivity in FD
56. Functional dyspepsia - symptoms
57. The pathophysiology of functional dyspepsia
58. Treatment paradox
59. Unclear natural history in functional dyspepsia
60. Diagnosis: functional dyspepsia
61. Treatment options for functional dyspepsia
62. Treatment strategy
63. Functional dyspepsia and diet
64. Treatment for H. pylori infection in NUD
65. H2RAs for functional dyspepsia
66. Randomized controlled trials of PPIs in NUD (1)
67. Randomized controlled trials of PPIs in NUD (2)
68. Prokinetic systematic review
69. Prokinetic therapy forest plot
70. Prokinetic results
71. Evidence for prokinetic therapies (1)
72. Evidence for prokinetic therapies (2)
73. Serotoninergic agents
74. Functional dyspepsia: SSRIs/SNRIs
75. Pain modulation (1)
76. Pain modulation (2)
77. Herbal remedies for functional dyspepsia
78. Non-pharmacological treatment

Topics Covered

• Gastroparesis symptoms, definition, and epidemiology
• Gastroparesis pathophysiology
• Gastroparesis treatment paradigms
• Functional dyspepsia symptoms, definition, and epidemiology
• Functional dyspepsia pathophysiology
• Functional dyspepsia treatment paradigms

Links

Series:

• Gastroenterology and Hepatology

Categories:

• Diseases, Disorders, & Treatments
• Metabolism & Nutrition

Talk Citation

Kuo, B. (2011), "Disorders of Gastric Function: Gastroparesis and Functional Dyspepsia", in The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, London (online at https://hstalks.com/bs/1904/)

Talk Information

• Published on January 11, 2011